Differentially expressed proteins in malignant and benign adrenocortical tumors

17Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

We have compared the microsomal protein composition of eight malignant and six benign adrenocortical tumors with proteomic methods. IGF2 had increased level in the malignant tumors, confirming previous microarray studies on the same material. Aldolase A, a glycolytic enzyme, also showed increased levels in the malignant tissue compared to the benign. Additionally, several proteins belonging to complex I in the mitochondrial respiration chain showed decreased levels in the malignant tissue. Taken together, this may indicate a shift in energy metabolism where glycolysis may be favored over tight coupling of glycolysis and mitochondrial respiration, a phenomenon known as the Warburg effect. One of the complex I proteins that showed decreased levels in the malignant tissue was GRIM-19. This protein has been suggested as a tumor suppressive protein by being a negative regulator of STAT3. In summary, an analysis of the microsomal proteome in adrenocortical tumors identifies groups of proteins as well as specific proteins differentially expressed in the benign and malignant forms. These proteins shed light on the biology behind malignancy and could delineate future drug targets. © 2014 Kjellin et al.

Cite

CITATION STYLE

APA

Kjellin, H., Johansson, H., Höög, A., Lehtiö, J., Jakobsson, P. J., & Kjellman, M. (2014). Differentially expressed proteins in malignant and benign adrenocortical tumors. PLoS ONE, 9(2). https://doi.org/10.1371/journal.pone.0087951

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free